Tracy Dobbs
Overview
Explore the profile of Tracy Dobbs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenz H, Philip P, Saunders M, Kolevska T, Mukherjee K, Samuel L, et al.
Cancer Chemother Pharmacol
. 2017 Oct;
80(6):1161-1169.
PMID: 29043412
Purpose: Etirinotecan pegol (EP) is a long-acting topoisomerase-I inhibitor designed to provide sustained exposure to SN-38 (active metabolite of irinotecan). This phase II study compared EP versus irinotecan as second-line...
2.
Jain A, Hughes R, Sandler A, Dowlati A, Schwartzberg L, Dobbs T, et al.
J Thorac Oncol
. 2009 May;
4(6):722-7.
PMID: 19404213
Introduction: The current standard of care for good performance status patients with locally advanced non-small cell lung carcinoma is concurrent chemoradiation, although a clearly superior regimen has not been identified....
3.
Dobbs T, Davis P, Dancer J
Percept Mot Skills
. 2005 Mar;
100(1):263-6.
PMID: 15773717
This study surveyed all licensed Arkansas audiologists (N = 127) regarding auditory processing disorders in children and adults, with 16 items covering demographic information, knowledge, identification and diagnosis, service provision,...
4.
Hesketh P, Arena F, Patel D, Austin M, DAvirro P, Rossi G, et al.
Cancer
. 2004 Feb;
100(4):859-68.
PMID: 14770445
Background: The effect of using fixed versus weight-based doses for erythropoietic agents has not been reported previously. To investigate this issue, the authors conducted a randomized Phase II study of...